首页> 外文期刊>RSC Advances >Tumor suppressor miR-449a inhibits the development of gastric cancer via down-regulation of SGPL1
【24h】

Tumor suppressor miR-449a inhibits the development of gastric cancer via down-regulation of SGPL1

机译:肿瘤抑制器miR-449a通过SGPL1的下调抑制胃癌的发展

获取原文
获取原文并翻译 | 示例
           

摘要

MicroRNAs (miRNAs) are small noncoding RNAs that are known to participate in the regulation of many physiological and pathological processes, which can indirectly influence the development of malignant behaviors. Numerous studies have demonstrated that miR-449a plays important roles in human carcinogenesis. However, its precise functional and regulatory roles remain unclear. In this study, we mainly explored the functional role of miR-449a in gastric cancer (GC). The expression levels of miR-449a in 98 cases of GC tissues and cell lines were determined by qRT-PCR. The possible mechanisms of miR-449a in GC cells were explored by fluorescence reporter assay. miR-449a expression was significantly lower in GC tissues compared to matched para-carcinoma tissues and was associated with tumor differentiation. Furthermore, in vitro knockdown of miR-449a by siRNA significantly inhibited MKN-28 cell proliferation, migration and invasion as well as tumorigenesis via inducing G0/G1 arrest of GC cells. In addition, we identified SGPL1 as a target of miR-449a and demonstrated that miR-449a regulated SGPL1 expression via binding its 3 '-UTR region. The experiments indicated that miR-449a functions as a novel tumor suppressor in GC and its anti-oncogenic activity may involve its inhibition of the target gene SGPL1. These findings suggested thatmiR-449amay be a promising candidate for the development of antitumor drugs targeting GC.
机译:微RNA(miRNA)是已知参与许多生理和病理过程的调控,其可以间接地影响恶性行为的发展小非编码RNA。大量研究证明了miR-449A在人类肿瘤发生的重要作用。然而,其精确的功能和调节作用仍不清楚。在这项研究中,我们主要探讨了胃癌(GC)的miR-449A的功能作用。的miR-449A的在GC组织和细胞系的98例的表达水平通过qRT-PCR测定。在GC细胞的miR-449A的可能机制通过荧光报道分子测定法探讨。的miR-449A表达在胃癌组织显著下相比匹配对 - 癌组织和与肿瘤分化相关联。此外,在体外诱导经由GC细胞的G0 / G1期阻滞的miR-449A通过siRNA抑制显著MKN-28细胞的增殖,迁移和侵入,以及肿瘤发生的击倒。此外,我们确定SGPL1为的miR-449A的一个目标,并证明了的miR-449A通过结合它的3“端非翻译区的区域调节SGPL1表达。实验表明了miR-449A用作在GC和其抗致癌活性的新的肿瘤抑制可能涉及其靶基因SGPL1的抑制。这些结果表明thatmiR-449amay是抗肿瘤靶向药物GC发展有希望的候选。

著录项

  • 来源
    《RSC Advances》 |2018年第46期|共9页
  • 作者单位

    Fudan Univ Minhang Hosp Dept Gen Surg 170 Xinsong Rd Shanghai 201199 Peoples R China;

    Fudan Univ Minhang Hosp Dept Gen Surg 170 Xinsong Rd Shanghai 201199 Peoples R China;

    Fudan Univ Minhang Hosp Dept Gen Surg 170 Xinsong Rd Shanghai 201199 Peoples R China;

    Fudan Univ Minhang Hosp Dept Gen Surg 170 Xinsong Rd Shanghai 201199 Peoples R China;

    Fudan Univ Minhang Hosp Dept Gen Surg 170 Xinsong Rd Shanghai 201199 Peoples R China;

    Fudan Univ Peoples Hosp Affiliated 5 Dept Infect Dis Shanghai 201199 Peoples R China;

    Fudan Univ Minhang Hosp Dept Gen Surg 170 Xinsong Rd Shanghai 201199 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号